Influence of nonalcoholic fatty liver disease on the therapeutic effect of nucleoside (acid) analogs for hepatitis B virus

doi:10.4254/wjh.v16.i12.1395

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (371)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-3) series.

Item

Count

PDF

HTML

214

Figures (1-5)

Tables (1-3)

Sum=312

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=41

Dec 27, 2024 (publication date) through Dec 22, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Hepatol. Dec 27, 2024; 16(12): 1395-1406
Published online Dec 27, 2024. doi: 10.4254/wjh.v16.i12.1395

Full Size Figure Download Figure

Figure 3 Biochemical response of chronic hepatitis B patients with and without nonalcoholic fatty liver disease by antiviral therapy at 24 months. A: Normalization rate of alanine aminotransferase (≤ 30 U/L and ≤ 19 U/L for males and females); B: Normalization rate of aspartate aminotransferase (≤ 40 U/L for males and females). NAFLD: Nonalcoholic fatty liver disease.

Citation: Li HD, Liu YN, Wu S, Quan XF, Wang XY, Xiang TD, Li SM, Xu L, Wang T, Wang H, Zheng X. Influence of nonalcoholic fatty liver disease on the therapeutic effect of nucleoside (acid) analogs for hepatitis B virus. World J Hepatol 2024; 16(12): 1395-1406
URL: https://www.wjgnet.com/1948-5182/full/v16/i12/1395.htm
DOI: https://dx.doi.org/10.4254/wjh.v16.i12.1395